Pradaxa maker reaches $650 million settlement in state and federal litigation
Thursday, May 29, 2014 - 07:00
in Health & Medicine
Veronica LinaresRIDGEFIELD, Conn., May 29 (UPI) -- Boehringer Ingelheim announced that it has reached a $650 million settlement in their state and federal cases in the U.S. regarding the blood thinner Pradaxa.